logo mainlogo darklogo main
  • Profile
  • People
  • Portfolio
  • Press
  • Contact Us
logo main logo darklogo light
  • Profile
  • People
  • Portfolio
  • Press
  • Contact Us
Glycocalyx-targeted therapy ameliorates age-related arterial dysfunction
February 14, 2023

Glycocalyx-targeted therapy ameliorates age-related arterial dysfunction

Advanced age is accompanied by arterial dysfunction, as well as a diminished glycocalyx, which may be linked to reduced high molecular weight–hyaluronan (HMW-HA) synthesis.

Read More
Dietary Glycocalyx Precursor Supplementation Ameliorates Age-Related Vascular Dysfunction
April 1, 2019

Dietary Glycocalyx Precursor Supplementation Ameliorates Age-Related Vascular Dysfunction

Large elastic artery stiffening and endothelial dysfunction, and associated reductions in nitric oxide (NO) bioavailability, are central features of vascular aging.

Read More
skeletal-muscle
April 15, 2014

Skeletal muscle capillary density and microvascular function are compromised with aging and type 2 diabetes

Impairments in microvascular structure and/or function with aging and type 2 diabetes have been associated with the progressive loss of skeletal muscle mass.

Read More
BioRegenx
About BioRegenx
  • Profile
  • People
  • Portfolio
  • Press
  • Contact Us
Get in touch

PO Box 21210
Chattanooga TN, 37424

(800) 398 - 9842

support@bioregenx.com

Headquarters in Chattanooga, TN
Additional Offices in Alpine, UT

Copyright © 2023 BioRegenx, Inc. All rights reserved

7407 Ziegler Rd Chattanooga, TN 37421

(800) 398 - 9842

support@bioregenx.com